Automation could thin Citigroup’s investment banking unit jobs: FT
June 12, 2018
U.S. reveals ZTE settlement details, ban still in place
June 12, 2018

Investors ready to resuscitate Johnson & Johnson’s ailing stock

NEW YORK (Reuters) – Johnson & Johnson shareholders have endured a painful year amid worries about prospects for its many businesses, but investors capitalizing on the stock’s relatively cheap valuation may be set to apply a Band-Aid to the declines.

Powered by WPeMatico